dronabinol has been researched along with Chromosomal Translocation in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guzmán, M; Oesch, S; Pretre, K; Salazar, M; Schäfer, BW; Velasco, G; Wachtel, M; Walter, D | 1 |
1 other study(ies) available for dronabinol and Chromosomal Translocation
Article | Year |
---|---|
Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma.
Topics: Animals; Apoptosis; Basic Helix-Loop-Helix Transcription Factors; Blotting, Western; Cell Proliferation; Dronabinol; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Immunoenzyme Techniques; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Proteins; Oncogene Proteins, Fusion; PAX7 Transcription Factor; Proto-Oncogene Proteins c-akt; Receptor, Cannabinoid, CB1; Receptors, Interleukin-2; Reverse Transcriptase Polymerase Chain Reaction; Rhabdomyosarcoma; RNA, Messenger; Translocation, Genetic; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2009 |